HEALTHCARE

Market Highlights: Pseudomonas Aeruginosa is a soil bacterium that causes diseases in a plant, animal and humans. It has an antibiotic resistance property because of which it creates life-threatening conditions that are difficult to treat. Pseudomonas Aeruginosa is one of the key reasons for having surgical site infection and hospital-acquired infection in patient hospitalized for a longer period. It is estimated that around 1.7 million patient suffers from hospital acquire infection and 99,000 dies each year from the same. According to MRFR analysis, the global Pseudomonas Aeruginosa Treatment Market is expected to register a CAGR of ~7% during the forecast period of 2019 to 2025 and is likely to be valued at USD 7.5 billion in 2025. The growth of the global Pseudomonas Aeruginosa treatment market is determined by numerous factors such as an increasing number of surgeries, a growing geriatric population, increasing cases of hospital-acquired infection, which is directly respo...